Manfred Fischer

Dr. Manfred Fischer is a Biophysical Chemist. He has more than 30-year experience in the pharmaceutical industry, mainly in the CMC arena covering analytical / formulation development of new and generic products and Quality Control of
medicinal products.

He started his career in the pharmaceutical industry at AstraZeneca with a leadership role in analytical development. As the next steps in his professional journey, he served in several managerial and leadership roles in analytical development and quality control at AstraZeneca, AltanaPharma, and Eli Lilly. In 2007 Manfred Fischer joined Skyepharma (later acquired by Vectura), Switzerland as head of analytical development. In 2017 he became VP of pharmaceutical development of inhalation
drug products at Vectura. He is the founder and General Manager of Manfred Fischer Consulting, a pharmaceutical company focusing on analytical, formulation and device development consulting.